Presentation is loading. Please wait.

Presentation is loading. Please wait.

Milena Lonati PD Quality Management DG2, European Patent Office

Similar presentations


Presentation on theme: "Milena Lonati PD Quality Management DG2, European Patent Office"— Presentation transcript:

1 Milena Lonati PD Quality Management DG2, European Patent Office
Trilateral Collaborative Metrics Study on International Search Reports PCT MIA Milena Lonati PD Quality Management DG2, European Patent Office Canberra, February 2012

2 Introduction In the Trilateral meeting of June 2010, the three Offices agreed to undertake a pilot collaborative study on quality metrics of International Search Reports. It was agreed that the EPO would coordinate the study and that a report would be made to the Trilateral in November 2011. The EPO thanks the JPO and USPTO for their essential contributions to study design, data collection and results analysis. 03/12/2018

3 Previous Individual ISR Studies
USPTO JPO EPO JIPA 03/12/2018

4 Benefits of a collaborative study
Common analysis Commonly defined sample Collaboration Commonly agreed approach Data exchange Combined resources Clearer Picture! Commonly defined parameters Use of PATSTAT data Commonly agreed metrics Larger samples 03/12/2018

5 Study approach Phase 1 Phase 2 Phase 3
Characteristics of ISRs produced by the Trilateral offices from Phase 2 Contribution of ISRs to national first actions. Inspection of a sample of 1152 files per ISA. Phase 3 Proposed detailed analysis of underlying causes of divergence based on a subset sample (postponed). Trilateral Conference, Autumn 2011 03/12/2018

6 Phase 1: ISR Characteristics Studied
Average Number of Citations Citation of Non-Patent Literature Trends and Differences Percentage of ISRs with X or Y Citations Citation Languages 03/12/2018

7 Percentage of ISRs With X or Y Category Citations
The trend for each office is statistically significant at a 95% level (* excepted) % of ISRs characterised "Y no X" * 03/12/2018

8 Patent And Non-Patent Literature Citations
Statistically significant increase at a 95% level (*) Difference EPO-JPO is due to non-patent literature (NPL) citations * Increase in average is due to a higher number of patent citations 03/12/2018

9 Non-official Language Citations
Official Languages JPO Japanese EPO English French German USPTO 03/12/2018

10 Phase 1 Conclusions Differences are observed between the Trilateral Offices in XY rates and their development over time, the level of "Y no X" ISRs, the average number of patent and non-patent literature citations and its trend over time, the level of non-official language citations. In order to obtain a better understanding of these differences and their consequences on ISR reuse, they should be further analysed. Pertinent prior art is often only available in a non-official language. The challenge of finding this art has to be addressed. For example enhancement of machine translation tools can help. 03/12/2018

11 Phase 2 Description Sample-based study of national phase first actions. Approx applications per national office (~3450 in total). Characteristics of analysed applications: International filing date 2006, searched by one of the Trilateral offices as ISA, received a national phase first action at any time thereafter. Each office collected data for applications which had entered its own national phase. 03/12/2018

12 PCT as a Filter Mechanism
Statistically significant difference at a 95% level (*) Claims not amended after a WOISA indicating that none of the claims is regarded as novel or inventive * * Amended Claims after a WOISA indicating that none of the claims is regarded as novel or inventive * 03/12/2018

13 Documents Cited in the National First Action
ISA = National Office 03/12/2018

14 Reuse & Agreement Study Results
Concept Description ISA = National Office ISA ≠ National Office Reuse of ISR citations for patentability objections in national first actions Partial reuse: at least one reused ISR citation EPO 99% 59% JPO 82% USPTO Complete reuse: only reused ISR citations 98% 16% 48% 18% National first action agreement with WOISA opinion on patentable subject matter No patentable subject matter in WOISA 90% 71% 86% WOISA with patentable subject matter 85% 37% 77% 42% 03/12/2018

15 Phase 2 Conclusions The PCT is valuable for applicants in order to
decide on further national phase prosecution and to overcome patentability objections early. Reuse of ISR citations: examiners do reuse ISR citations, however, many new documents are found in the national phase. Hence, enhancement of ISRs would result in more efficient national first actions. Agreement on patentability: agreement is high where the WOISA does not acknowledge patentability ("negative" cases), agreement is low where the WOISA acknowledges patentability ("positive" cases), when ISA ≠ national office. Hence, enhancement of ISRs would also improve consistency between PCT and national phases. 03/12/2018

16 Achievements And Final Conclusions
The study has Provided insight into current working of the PCT & areas for improvement. Enhanced mutual understanding of common and differing practice. Developed a basis for ongoing collaboration. Established metrics benchmarks. A technical environment has been created that can be reused for further monitoring or expanded to other offices (e.g. IP5). Benefits in terms of quality, efficiency and reduction of backlogs can be achieved if the potential of reuse of ISRs is further enhanced. 03/12/2018

17 Thank you for your attention!
03/12/2018


Download ppt "Milena Lonati PD Quality Management DG2, European Patent Office"

Similar presentations


Ads by Google